| miR-132 functions as a tumor suppressor in osteosarcoma and that its suppressive effects are mediated chiefly by repressing CCNE1 expression. | osteosarcoma, |
| study indicated that miR-212/132 functions as tumor suppressor by targeting SMAD2 in cervical cancer | cervical, |
| miR-132 functions as a tumor suppressor in hepatocellular carcinoma | liver, |
| Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer | prostate, |
| MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor | pancreatic, |
| miR-132 and miR-212 cluster function as a tumor suppressor in thyroid cancer cells by CSDE1 mediated post-transcriptional program | thyroid, |
| MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11 | lymphoma, |
| Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma | lung, |
| The study of this study suggests that miR-132 is an important tumor suppressor of astrocytoma progression by targeting PEA-15, while CREB and KLF can modulate the expression of miR-132. | None |
| miR-132 plays an important oncogenic role in LSCC by modulating the PI3K/AKT/FOXO1 pathway | None |